Since Ang II stimulates cardiovascular growth and remodeling by binding to AT1R, many AT1R blockers such as losartan, valsartan, telmisartan and candesartan have shown to attenuate cardiac hypertrophy [153,154,155,156]. This evidence concerns the gene AGTR1 and cardiac hypertrophy.